CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 31.85
+0.20 (0.63%)
May 13, 2025, 4:08 PM HKT
CanSino Biologics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 1,521 | - | 2,822 | 3,465 | 5,645 | 4,447 | Upgrade
|
| Short-Term Investments | - | - | - | - | 275.2 | - | Upgrade
|
| Trading Asset Securities | 1,567 | - | 1,308 | 2,482 | 1,862 | 666.64 | Upgrade
|
| Cash & Short-Term Investments | 3,088 | 3,283 | 4,130 | 5,947 | 7,783 | 5,114 | Upgrade
|
| Cash Growth | -23.08% | -20.50% | -30.55% | -23.59% | 52.19% | 577.49% | Upgrade
|
| Accounts Receivable | 665.93 | - | 636.88 | 855.49 | 157.93 | 22.14 | Upgrade
|
| Other Receivables | 11.56 | - | 3.98 | 0.54 | 19.15 | 0.25 | Upgrade
|
| Receivables | 677.49 | - | 640.87 | 856.03 | 177.08 | 22.4 | Upgrade
|
| Inventory | 322.56 | - | 352.85 | 677.78 | 875.62 | 170.51 | Upgrade
|
| Prepaid Expenses | - | - | 0.25 | - | - | - | Upgrade
|
| Other Current Assets | 45.97 | - | 57 | 249.59 | 454.49 | 114.07 | Upgrade
|
| Total Current Assets | 4,134 | - | 5,181 | 7,730 | 9,290 | 5,421 | Upgrade
|
| Property, Plant & Equipment | 2,636 | - | 3,013 | 3,069 | 2,218 | 873.95 | Upgrade
|
| Long-Term Investments | 16.22 | - | 446.56 | 50.12 | 45.31 | 265.44 | Upgrade
|
| Other Intangible Assets | 112.21 | - | 144.15 | 220.92 | 172.12 | 36.9 | Upgrade
|
| Long-Term Deferred Tax Assets | 210.57 | - | 207.86 | 196.41 | - | - | Upgrade
|
| Long-Term Deferred Charges | 172.32 | - | 88.4 | 51.95 | 26.19 | 43.37 | Upgrade
|
| Other Long-Term Assets | 538.58 | - | 237.53 | 150.37 | 122.42 | 107.78 | Upgrade
|
| Total Assets | 7,820 | - | 9,319 | 11,469 | 11,874 | 6,748 | Upgrade
|
| Accounts Payable | 56.75 | - | 103.97 | 253.12 | 842.57 | 60.57 | Upgrade
|
| Accrued Expenses | 136.68 | - | 453.14 | 407.25 | 362.44 | 157.82 | Upgrade
|
| Short-Term Debt | 213.62 | - | 883.97 | 1,530 | 990.68 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 510.59 | 45.77 | 90.11 | 40.16 | Upgrade
|
| Current Portion of Leases | - | - | 64.63 | 48.76 | 31.18 | 8.59 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.54 | 3 | 29.14 | - | Upgrade
|
| Current Unearned Revenue | 37.89 | - | 3.57 | 1.48 | 193.22 | 0.42 | Upgrade
|
| Other Current Liabilities | 1,115 | - | 544.9 | 635.52 | 322.08 | 141.91 | Upgrade
|
| Total Current Liabilities | 1,560 | - | 2,565 | 2,925 | 2,861 | 409.47 | Upgrade
|
| Long-Term Debt | 1,115 | - | 1,066 | 878.01 | 40 | 90 | Upgrade
|
| Long-Term Leases | 11.11 | - | 175.18 | 198.29 | 222.85 | 3.79 | Upgrade
|
| Long-Term Unearned Revenue | 236.01 | - | 216.72 | 222.35 | 201.48 | 173.96 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.56 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 8.49 | - | - | - | Upgrade
|
| Total Liabilities | 2,922 | - | 4,031 | 4,223 | 3,326 | 677.22 | Upgrade
|
| Common Stock | 247.45 | - | 247.45 | 247.45 | 247.45 | 247.45 | Upgrade
|
| Additional Paid-In Capital | 6,577 | - | 6,574 | 6,608 | 6,598 | 6,588 | Upgrade
|
| Retained Earnings | -1,830 | - | -1,440 | 42.71 | 1,150 | -764.69 | Upgrade
|
| Treasury Stock | -95.62 | - | -106.17 | -150.17 | - | - | Upgrade
|
| Comprehensive Income & Other | 0.22 | - | -0.18 | 0.12 | - | - | Upgrade
|
| Total Common Equity | 4,899 | 5,063 | 5,275 | 6,748 | 7,995 | 6,071 | Upgrade
|
| Minority Interest | - | - | 12.81 | 497.51 | 552.84 | - | Upgrade
|
| Shareholders' Equity | 4,899 | 5,063 | 5,287 | 7,246 | 8,548 | 6,071 | Upgrade
|
| Total Liabilities & Equity | 7,820 | - | 9,319 | 11,469 | 11,874 | 6,748 | Upgrade
|
| Total Debt | 1,340 | 2,102 | 2,700 | 2,701 | 1,375 | 142.54 | Upgrade
|
| Net Cash (Debt) | 1,749 | 1,181 | 1,430 | 3,246 | 6,408 | 4,971 | Upgrade
|
| Net Cash Growth | 11.03% | -17.41% | -55.95% | -49.34% | 28.90% | 745.44% | Upgrade
|
| Net Cash Per Share | 7.17 | 4.77 | 5.80 | 13.14 | 25.91 | 21.56 | Upgrade
|
| Filing Date Shares Outstanding | 230.91 | 249.18 | 247.04 | 246.77 | 247.45 | 247.45 | Upgrade
|
| Total Common Shares Outstanding | 230.91 | 249.18 | 247.04 | 246.77 | 247.45 | 247.45 | Upgrade
|
| Working Capital | 2,575 | - | 2,616 | 4,805 | 6,428 | 5,011 | Upgrade
|
| Book Value Per Share | 21.22 | 20.58 | 21.35 | 27.35 | 32.31 | 24.53 | Upgrade
|
| Tangible Book Value | 4,787 | 4,944 | 5,130 | 6,527 | 7,823 | 6,034 | Upgrade
|
| Tangible Book Value Per Share | 20.73 | 20.10 | 20.77 | 26.45 | 31.61 | 24.38 | Upgrade
|
| Buildings | - | - | 978.89 | 729.03 | 724.68 | 37.19 | Upgrade
|
| Machinery | - | - | 1,189 | 1,050 | 537.75 | 120.73 | Upgrade
|
| Construction In Progress | - | - | 1,114 | 1,342 | 820.8 | 760.05 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.